India's patently wise rule favors patients

THE Indian Supreme Court's refusal to uphold the patent on Gleevec, the blockbuster cancer drug developed by the Swiss pharmaceutical giant Novartis, is good news for many in India suffering from cancer.

http://www.shanghaidaily.com/nsp/Opinion/2013/04/12/Indias%2Bpatently%2Bwise%2Brule%2Bfavors%2Bpatients/